Finance

Beta
Lists
ACHV:NASDAQ
Achieve Life Sciences Inc
$5.70
+7.55%
(+0.40) 1D
$5.73
+0.53% (+0.030)
After hours
Closed: Jun 25, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACHV...
Open
$5.25
High
$6.00
Low
$5.24
Mkt. cap
585.16M
Avg. vol.
1.73M
Volume
3.80M
52-wk high
$6.16
52-wk low
$2.00
EPS
-$1.11
Beta
2.27
Shares outstanding
102.66M
No. of employees
28
Open
$5.25
High
$6.00
Low
$5.24
Mkt. cap
585.16M
Avg. vol.
1.73M
Volume
3.80M
52-wk high
$6.16
52-wk low
$2.00
EPS
-$1.11
Beta
2.27
Shares outstanding
102.66M
No. of employees
28
News stories
From sources across the web
About Achieve Life Sciences Inc
CEO-
Employees28
Founded1991
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteachievelifesciences.com
Analyst ratings
Based on 5 analysts giving stock ratings to ACHV in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ACHV in the last 3 months.
Highest
Current $5.70
$20.00 (+250.88%)
Average
$13.20 (+131.58%)
Lowest
$10.00 (+75.44%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
$10.00
+75.4%
06/22/2026
Gary Nachman
Canaccord Genuity
Buy
Reiterated
$13.00
+128.1%
06/23/2026
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
$12.00
+110.5%
06/23/2026
Mark Smith
Lake Street
Buy
Maintained
$11.00
+93%
05/13/2026
Justin Walsh
JonesTrading
Buy
Reiterated
$20.00
+250.9%
05/12/2026
Unknown Analyst
Canaccord Genuity
Buy
Initiated
$13.00
+128.1%
04/20/2026
Thomas Flaten
Lake Street
Buy
Maintained
$11.00
+93%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6.71M
5.32M
3.87M
3.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.86M
9.37M
10.86M
7.17M
Operating expense
12.56M
14.69M
14.73M
10.46M
Total operating expenses
12.56M
14.69M
14.73M
10.46M
Operating income
-12.56M
-14.69M
-14.73M
-10.46M
Other non operating income
-59.00K
-5.00K
7.00K
-13.00K
EBT including unusual items
-12.72M
-14.44M
-14.66M
-10.17M
EBT excluding unusual items
-12.62M
-14.34M
-14.55M
-10.45M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12.72M
-14.44M
-14.66M
-10.17M
Net profit margin
-
-
-
-
Earnings per share
-0.37
-0.28
-0.28
-0.19
Interest and investment income
192.00K
554.00K
427.00K
297.00K
Interest expense
-191.00K
-192.00K
-251.00K
-274.00K
Net interest expenses
1.00K
362.00K
176.00K
23.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.51M
-14.64M
-14.67M
-10.41M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of ACHV
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer